A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

“The 2024–2025 COVID vaccine, which was released last fall, is still recommended for everyone aged six months or over,” the ...

New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get ...

New requirements for clinical testing of vaccines, announced this month, may delay the availability of shots that had ...

The FDA announced that it would only allow COVID-19 vaccinations for those 65 years of age and over and those with certain ...

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...